Atika Capital Management LLC Bridge Bio Pharma, Inc. Transaction History

Atika Capital Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$24.02 - $43.89 $216,180 - $395,010	9,000 New	9,000 $363,000
Q1 2023 May 12, 2023	BUY	$7.17 - $18.55 $645,300 - $1.67 Million	90,000 New	90,000 $1.49 Million
Q4 2021 Feb 11, 2022	SELL	$11.38 - $53.41 $836,430 - $3.93 Million	-73,500 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$46.87 - $64.24 $51,557 - $70,664	1,100 Added 1.52%	73,500 $3.45 Million
Q2 2021 Aug 12, 2021	SELL	$46.47 - $63.93 $232,350 - $319,650	-5,000 Reduced 6.46%	72,400 $4.41 Million
Q1 2021 May 14, 2021	BUY	$55.47 - $72.35 $366,102 - $477,509	6,600 Added 9.32%	77,400 $4.77 Million
Q4 2020 Feb 16, 2021	BUY	$38.38 - $71.11 $318,554 - $590,213	8,300 Added 13.28%	70,800 $5.04 Million
Q3 2020 Nov 13, 2020	SELL	$27.2 - $42.19 $1.15 Million - $1.78 Million	-42,300 Reduced 40.36%	62,500 $2.35 Million
Q2 2020 Aug 13, 2020	SELL	$22.22 - $35.69 $104,434 - $167,743	-4,700 Reduced 4.29%	104,800 $3.42 Million
Q1 2020 May 14, 2020	BUY	$16.11 - $36.23 $1.31 Million - $2.94 Million	81,200 Added 286.93%	109,500 $3.18 Million
Q4 2019 Feb 14, 2020	BUY	$17.96 - $46.63 $508,268 - $1.32 Million	28,300 New	28,300 $991,000

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.45B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Atika Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Atika Capital Management LLC with notifications on news.